CHINA PHARMA HOLDINGS, INC. Earnings Per Share Diluted

Quick Answer

CHINA PHARMA HOLDINGS, INC. reported Earnings Per Share Diluted of $0.27 (loss) per share for the year ending 2024.

  • CHINA PHARMA HOLDINGS, INC. showed an increase of +70.3% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2010 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2010 to 2024), CHINA PHARMA HOLDINGS, INC.'s Earnings Per Share Diluted has declined by 150.0%.
  • Historical annual values: Fiscal year 2024: $0.27 (loss) per share | Fiscal year 2023: $0.91 (loss) per share | Fiscal year 2022: $3.78 (loss) per share | Fiscal year 2021: $0.74 (loss) per share | Fiscal year 2015: $0.35 (loss) per share | Fiscal year 2014: $0.91 (loss) per share | Fiscal year 2013: $0.46 (loss) per share | Fiscal year 2012: $0.11 per share | Fiscal year 2011: $0.44 per share | Fiscal year 2010: $0.54 per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: